82 related articles for article (PubMed ID: 615457)
21. [LDH activity of the serum and malignant tissue in patients with ovarian tumors].
Jandová A; Kubátová A; Macků F; Novatná J; Pezlarová A
Cesk Gynekol; 1971 Nov; 36(9):549-50. PubMed ID: 5135596
[No Abstract] [Full Text] [Related]
22. Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas.
Nakayama T; Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Asayama Y; Matake K; Kakihara D; Matsuura S; Nakano H; Honda H
J Magn Reson Imaging; 2005 Aug; 22(2):271-8. PubMed ID: 16028258
[TBL] [Abstract][Full Text] [Related]
23. Comparison of L-lactate: NAD+-oxidoreductase (E.C.1.1.1.27) and its isoenzymes with the L/S index in premature and term infants.
Pokorný A; Jandová A; Sorfová J; Melková J; Pezlarová J; Cerný J
Acta Univ Carol Med Monogr; 1977; (78 Pt 2):109-16. PubMed ID: 615455
[No Abstract] [Full Text] [Related]
24. Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
Haeger M; Swahn M; Hahlin M; Horvath G; Bengtsson A
Anticancer Res; 1996; 16(5B):3189-92. PubMed ID: 8967734
[TBL] [Abstract][Full Text] [Related]
25. [Validity of Gynaegnost in the follow-up of patients treated for ovarian cancer].
Cerejeira L; Pinto-Ferreira MM; Otilia-Bacelar MO; Moutinho J
Rev Fr Gynecol Obstet; 1989 Apr; 84(4):347-9. PubMed ID: 2734533
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
[TBL] [Abstract][Full Text] [Related]
27. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
Wahlberg K; Høyer-Hansen G; Casslén B
Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
[TBL] [Abstract][Full Text] [Related]
28. [Malignant Brenner tumours (author's transl)].
Motlík K; Hejda V; Hanika J
Sb Lek; 1974 May; 76(4):116-24. PubMed ID: 4841805
[No Abstract] [Full Text] [Related]
29. Lactate dehydrogenase (LDH) isoenzymes patterns in ocular tumours.
Singh R; Kaurya OP; Shukla PK; Ramputty R
Indian J Ophthalmol; 1991; 39(2):44-7. PubMed ID: 1916977
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic and pathogenetic significance of determining lactate dehydrogenase isoenzyme activity in various biological media in patients with viral hepatitis].
Andriutsa KA; Andriutsa AK
Ter Arkh; 1987; 59(2):89-94. PubMed ID: 3576486
[TBL] [Abstract][Full Text] [Related]
31. Aspiration cytology and E2 content in ovarian tumors.
Geier GR; Strecker JR
Acta Cytol; 1981; 25(4):400-6. PubMed ID: 6945006
[TBL] [Abstract][Full Text] [Related]
32. [Serum lactic dehydrogenase assay in the diagnosis and therapeutic monitored of ovarian carcinoma].
Mi RR
Zhonghua Fu Chan Ke Za Zhi; 1985 Mar; 20(2):81-4, 126. PubMed ID: 2988875
[No Abstract] [Full Text] [Related]
33. [Placental protein 12 (PP 12) in cyst and peritoneal fluids and serum samples of patients with ovarian cysts and cystic ovarian tumors].
Strache RR; Göcze PM; Szábo DG; Büttner HH; Briese V; Kunze M; Csaba IF; Röpcke G
Zentralbl Gynakol; 1989; 111(11):749-54. PubMed ID: 2781888
[TBL] [Abstract][Full Text] [Related]
34. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
[TBL] [Abstract][Full Text] [Related]
35. [Changes of isoenzymes of lactate dehydrogenase under the influence of ionizing radiation. 3. Results of the study of the LDH-isoenzymes during radiation therapy].
Kärcher KH; Kato HT
Strahlentherapie; 1965 Jul; 127(3):439-51. PubMed ID: 4954157
[No Abstract] [Full Text] [Related]
36. LDH isoenzymes in the serum of patients with malignant diseases.
Roguljić A; Demirović J
Acta Med Iugosl; 1980 Nov; 34(4):315-24. PubMed ID: 7468308
[No Abstract] [Full Text] [Related]
37. [Clinical practice guidelines: Presumed benign ovarian tumors--aims, methods, and organization].
Brun JL; Fritel X; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):710-4. PubMed ID: 24210232
[No Abstract] [Full Text] [Related]
38. The preoperative diagnosis of malignancy of ovarian cysts.
Tropé C
Neoplasma; 1981; 28(1):117-21. PubMed ID: 7279055
[TBL] [Abstract][Full Text] [Related]
39. [The present status of tumor markers in malignant ovarian tumor].
Nishimura H; Miyoshi T; Hamai J; Miyahara K
Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
[TBL] [Abstract][Full Text] [Related]
40. [Determination of carcinoembryonic antigen in puncture fluid of cystic ovarian tumors and ovarian cysts].
Büttner HH; Kunze M; Voss P
Gynakol Rundsch; 1988; 28 Suppl 2():179-80. PubMed ID: 3234915
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
